Evidence map›Paper›PMID 40623846›Full record

ArticleClinical transplantation and research2025

Impact of probiotic supplementation on kidney transplantation outcomes: a retrospective propensity score matched study.

Yookyung Jang, Tai Yeon Koo, Young-Eun Choi, Cheol Woong Jung, Young Ju Oh, Heungman Jun, Sewon Oh, Sang-Kyung Jo, Myung-Gyu Kim

Abstract read
In one paragraph

Article in Clinical transplantation and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yookyung JangDepartment of Nephrology and Hypertension, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0009-0008-5948-5889
Tai Yeon KooDepartment of Nephrology and Hypertension, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0003-2014-7723
Young-Eun ChoiDepartment of Nephrology and Hypertension, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-7837-602X
Cheol Woong JungDepartment of Surgery, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-0776-8202
Young Ju OhDepartment of Surgery, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-7294-0160
Heungman JunDepartment of Surgery, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0003-2530-4388
Sewon OhDepartment of Nephrology and Hypertension, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0003-3795-9322
Sang-Kyung JoDepartment of Nephrology and Hypertension, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-0496-0258
Myung-Gyu KimDepartment of Nephrology and Hypertension, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-8807-2452

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The potential benefits and risks of probiotic use in kidney transplant (KT) recipients remain unclear. This study aimed to evaluate the effects of probiotic supplementation on KT outcomes. Methods: A retrospective analysis was performed using medical records from 354 KT recipients between January 2010 and December 2020. Only patients who received probiotics within the first year following transplantation were included, and transplant outcomes were assessed at 1-3 years after KT. Results: Among the 354 patients, 97 (27%) received probiotics during the study period, and 36 (10%) used them for more than 3 months. Probiotic types included Conclusions: This study identified a significant association between probiotic use and the occurrence of CMV viremia in KT recipients. To better define the safety and efficacy of probiotics in immunocompromised patients, large-scale prospective studies are necessary to establish comprehensive evidence.

Indexed as

Chronic kidney diseaseCytomegalovirus infectionKidney transplantationProbiotics

Identifiers

PMID40623846
PMCPMC12783011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.